Scott Mendel - 11 Jun 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Scott Mendel
Issuer symbol
AKYA
Transactions as of
11 Jun 2021
Net transactions value
$0
Form type
4
Filing time
15 Jun 2021, 21:59:37 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Stock Option (Right to Buy Award $0 +35,562 $0.000000 35,562 11 Jun 2021 Common Stock 36,562 $19.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continuous service through the vesting date, the options shall vest in three (3) equal installments beginning on June 11, 2022 and annually thereafter until fully vested.